Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGDOx in Relapsed or Refractory Non-Hodgkin Lymphoma
NCT01019863Phase 2Unknown
- Sponsor
- Centre de recherche du CHUS
- Start
- Oct 2008
- Primary completion
- Oct 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in non-Hodgkin lymphoma (NHL), sponsored by Centre de recherche du CHUS. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01019863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019863.